1. I don’t know anybody with polio. Back in the fifties, before parents became their children’s best friends, when if you refused to toe the...
Europe's medicines regulator said on May 7 the EMA has begun a real-time review of the Covid-19 antibody treatment developed by GSK and Vir Biotechnology,, formally...
Results from the initial primary analysis of the Novavax Covid-19 vaccine trial conducted by Wits VIDA in SA have been published. Credit: Wits University The published...
Futures Flat As Traders Look For Buying Catalyst For the fourth morning in a row, futures are barely changed - a stark reversal to the previous...
India gave emergency use authorization for a Covid-19 antibody drug cocktail developed by Roche and Regeneron, expanding the company's arsenal of drugs to battle a massive...
Coronavirus is 30,000 RNA 'letters' long, meaning there are over a quintillion possible genome permutations.
An imperfectly applied risk model led to the devastating situation India is facing today.
CNBC Exclusive: CNBC Transcript: Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla Speaks with CNBC’s “The Exchange” Today Q1 2021 hedge fund letters, conferences and more...
Next year, people are likely to need an annual Covid-19 vaccination just like they need an annual flu shot. That prediction is made by researchers at...
Europe’s regulator has begun a rolling review of Sinovac’s COVID-19 vaccine, known as Vero Cell. The vaccine is The post EU starts rolling review of Sinovac’s...
An experimental monoclonal antibody treatment for Covid-19 being developed by Eli Lilly and Co. and AbCellera Biologics Inc. can "potently" neutralize numerous coronavirus variants, including those first...
In this eBook, sponsored by Sartorius, we highlight the research efforts and related applications utilized to study binding affinity, potency and target specificities of neutralizing antibodies...
The CDC first paused, then unpaused, the administration of the Johnson & Johnson COVID-19 vaccine due to concerns about blood clots. But what are those clots,...
Penny stocks are back and better than ever; should you watch these 3 in May? The post 3 Penny Stocks With Huge Potential in May 2021...
Adeno-associated virus (AAV) vectors are the leading vectors for gene delivery. AAV vectors pose challenges including costly manufacture, high percentages of empty capsids, and safety issues...
CloseCloseCloseHealthcare has been lagging the market, but that is now changing.As biotechs consolidate, other healthcare industry groups are powering the sector to a breakout.Medical Devices and...
A single dose of Pfizer's coronavirus vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already...
The developments are coming in thick and fast at Sorrento Therapeutics (SRNE). Recent times have seen a flurry of announcements regrading the company’s bulging pipeline. Earlier...
The European Medicines Agency will conduct an accelerated review of Eli Lilly and Co.'s rheumatoid arthritis drug Olumiant for hospitalized Covid-19 patients getting oxygen, the EU...
Leaked documents from provincial and municipal governments in China reveal a slew of previously unreported severe adverse events related to Covid-19 vaccines made and administered in...
A DNA vaccine candidate for MERS-CoV induced potent immune responses and afforded protective efficacy in non-human primate models when given intradermally in a low-dose immunization regimen....
As a massive Covid-19 surge continues to rage on throughout India, scientists and public health officials scramble to determine whether currently authorized vaccines in the country...
The CDC and FDA said the benefits of the Johnson & Johnson vaccine far outweigh the low risk of developing rare blood clots and lifted a...
Enrollment begins at NIH Clinical Center Credit: NIAID A study assessing how people with immune system deficiencies or dysregulations respond to COVID-19 vaccination has begun enrolling...
The same group at the University of Oxford and the Jenner Institute that developed the AstraZeneca-Oxford Covid-19 vaccine reported that their investigational malaria vaccine, R21/Matrix-M, demonstrated...
The FDA has approved GlaxoSmithKline’s Jemperli (dostarlimab) immunotherapy, a drug acquired through its $5.1 billion acquisition of Tesaro, The post FDA approves under-pressure GSK’s Jemperli for...
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports. The post Xphyto...
From asymptomatic SARS-CoV-2 carriers to hospitalized COVID-19 patients, little is known about the relationship between the severity of disease and the extent of the immune response....
Credit: NIAID A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild...
Swiss drugmaker Roche predicted on April 21 that demand for the company's drugs would accelerate for the remainder of 2021, after first-quarter sales of Covid-19 tests...